MedTrace Logo

Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery

NCT01570530 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-09-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of atorvastatin therapy (both during preoperative and postoperative period), as prophylaxis against postoperative atrial fibrillation after cardiac surgery, in a valve disease patient population (with or without associated coronary artery disease), with no previous history of atrial fibrillation and not receiving beta-blocking drugs.

Conditions

Interventions

PROCEDURE

Cardiac surgery

Atorvastatin therapy as prophylaxis against postoperative atrial fibrillation after cardiac surgery

PROCEDURE

Cardiac surgery

Without atorvastatin therapy as prophylaxis against postoperative atrial fibrillation after cardiac surgery

Sponsors & Collaborators

  • Fundación General Universidad de Valladolid

    lead OTHER

Principal Investigators

  • Yolanda Carrascal Hinojal, M.D · Hospital Clínico Universitario de Valladolid

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-06-30
Completion
2014-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01570530 on ClinicalTrials.gov